66
Participants
Start Date
August 1, 2022
Primary Completion Date
May 1, 2023
Study Completion Date
July 10, 2023
Quadratus lumborum (QL) block group
patient will receive 0.5 mg/kg of bupivacaine 0.25% through the quadratus lumborum block approach
Pericapsular Nerve Group (PENG) block group
patient will receive 0.5 mg/kg of bupivacaine 0.25% through the Pericapsular Nerve Group (PENG) block
faculty of medicine, Zagazig university, Zagazig
Zagazig University
OTHER_GOV